According to a new report published by Allied Market Research, titled, โGenitourinary Drugs Market – Global Opportunity Analysis and Industry Forecast, 2022-2029” Genitourinary tract agents are medicines used to treat conditions of reproductive organs and excretory system or urinary tract. They include medicines used for bladder spasms, urinary pH modifiers, medicines for erectile dysfunction in men, and medicines that suppress uterine contractions to prevent preterm labor.
Types of genitourinary drugs include impotence agents, miscellaneous genitourinary tract agents, tocolytic agents, urinary antispasmodics, urinary pH modifiers, and uterotonic agents. Alpha-blockers relax smooth muscles in benign prostatic hyperplasia producing an increase in urinary flow rate and improvement in obstructive symptoms. Alpha-blockers are the treatment of choice for benign prostatic obstruction, and are likely to provide symptom relief in men with prostates of any size.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ ๐๐จ๐ฎ๐๐ก๐๐ซ: https://www.alliedmarketresearch.com/request-sample/10861
Surge in prevalence of genitourinary disorders is expected to boost the industry during the forecast period. Increase in number of pipeline drugs for genitourinary disorder is also expected to propel the market growth in coming years. Furthermore, surge in number of generics launched by big pharmaceutical companies as well as small and medium-sized drug manufacturers are anticipated to help the industry gain higher revenue in the next few years.
Growth in number of product launches is expected to help the industry flourish during the forecast period. For instance, in November 2019, the FDA approved cefiderocol (FETROJA) in patients of 18 years of age or older who have limited or no alternative treatment options, for complicated urinary tract infections (cUTI), including pyelonephritis, caused by susceptible Gram-negative microorganisms such as Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacae complex.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ: https://www.alliedmarketresearch.com/purchase-enquiry/10861
COVID-19 Scenario Analysis:
Pharmaceutical and biotechnological companies together with governments around the globe are working to combat the COVID-19 outbreak. This is carried out by supporting development of vaccines to schedule for medicines supply chain challenges. Furthermore, there are around 115 vaccine candidates and other 155 molecules that are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have seen huge boost in demand for management of COVID-19. There is an increase in demand for the drug, which has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of the drug. Hence, owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is anticipated to witness a substantial growth in the next few years.
๐๐๐ฒ ๐๐๐ง๐๐๐ข๐ญ๐ฌ:
- This study presents the analytical depiction of the global genitourinary drugs industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global genitourinary drugs market share.
- The current market is quantitatively analyzed from 2020 to 2027 to highlight the global genitourinary drugs market growth scenario.
- Porterโs five forces analysis illustrates the potency of buyers & suppliers in the genitourinary drugs market.
- The report provides a detailed global genitourinary drugs market analysis based on competitive intensity and how the competition will take shape in coming years.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง: https://www.alliedmarketresearch.com/purchase-enquiry/10861
Comprehensive competitive analysis and profiles of major market players such Abbott, Bristol-Myers Squibb Co., Novartis AG, Genentech, Inc., F. Hoffmann-La Roche Ltd, Ionis Pharmaceuticals, Inc., Eli Lilly and Company, Merck & Co., Inc., Pfizer, Inc. and AstraZeneca
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Surgical Robotic System Market: https://www.alliedmarketresearch.com/surgical-robotic-systems-market-A06827
Healthcare Interoperability Solutions Market: https://www.alliedmarketresearch.com/healthcare-interoperability-solutions-market-A07075
Surgical Drains Market https://www.alliedmarketresearch.com/wound-drainage-surgical-drains-market-A07517
๐๐๐จ๐ฎ๐ญ ๐๐ฌ
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com